Login

Aarti Drugs Ltd.

₹330.3

Overview Charts Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Corp. Action Documents
Consolidated
Standalone

Aarti Drugs Ltd.

₹330.3

₹330.3

8.55 (2.66%) - 8 Apr 2025 04:27 PM

About Company

Aarti Drugs Limited was established in the year 1984 and forms part of Aarti Group of Industries with robust R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.

Market Cap. ₹2,937 Cr.
52 Week - High/Low ₹635/312
P/E Ratio 22.33
P/B Ratio 2.50
Enterprise Value ₹3,245 Cr.
ROE % 12.39
RSI Value 36.32
EMA 50 371.65
EMA 200 439.11
Net Profit 142 Cr.
Net Profit 3year growth -44.95 Cr.
Net Profit 3 year (back) 258 Cr.
Debt to Equity 0.4 %
EPS Growth TTM -16.22 %
Current Ratio 1.73 %
100 Day SMA 410 Rs.
200 Day SMA 466 Rs.
21 Day SMA 348 Rs.
50 Day SMA 373 Rs.
Book Value 129 Rs.
EV/EBITDA Ratio 13
QoQ EPS Growth 27 %
QoQ Operating Profit Growth 1 %
QoQ Sales Growth -5 %
Sales Latest Quarter 515 Cr.
YoY Sales Growth -4 %
Market Cap. ₹2,937 Cr.
52 Week - High/Low ₹635/312
P/E Ratio 19.31
P/B Ratio 2.29
Enterprise Value ₹3,282 Cr.
ROE % 13.87
RSI Value 36.32
EMA 50 371.65
EMA 200 439.11
Net Profit 171 Cr.
Net Profit 3year growth -3.8 Cr.
Net Profit 3 year (back) 280 Cr.
Debt to Equity 0.44 %
EPS Growth TTM -14.7 %
Current Ratio 1.66 %
100 Day SMA 410 Rs.
200 Day SMA 466 Rs.
21 Day SMA 348 Rs.
50 Day SMA 373 Rs.
Book Value 140 Rs.
EV/EBITDA Ratio 11
QoQ EPS Growth 6 %
QoQ Operating Profit Growth -8 %
QoQ Sales Growth -7 %
Sales Latest Quarter 557 Cr.
YoY Sales Growth -8 %
Add Parameters

Growth

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages

Yearly

Insight market
Terms | Privacy | Contact Us
Copyright © 2025 All rights reserved with INVESMATE INSIGHTS PRIVATE LIMITED | All logos and Trademarks registered with their respective owners.